Skip to main content
Top
Published in: Inflammation 2/2015

01-04-2015

The Relationship Between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity

Authors: Ozlem Abakay, Abdurrahman Abakay, Hadice Selimoglu Sen, Abdullah C. Tanrikulu

Published in: Inflammation | Issue 2/2015

Login to get access

Abstract

We aimed to investigate the correlation between red cell distribution width (RDW), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and other inflammatory markers with pulmonary tuberculosis (PTB) severity. Seventy patients with active pulmonary tuberculosis were compared with 50 age-matched and gender-matched healthy controls. The mean age of PTB patients was 50.4 ± 21.8 years. There were no differences in terms of age, gender, and smoking history between PTB patients and controls. Patients with advanced PTB had a significantly higher white blood cell count, neutrophil count, RDW, NLR, and C-reactive protein when compared to patients with mild to moderate PTB. RDW (17.7 versus 15.7 %, p = 0.002) and NLR (4.7 versus 3.1, p = 0.009) values were higher in patients with advanced PTB as opposed to patients with mild to moderate PTB. NLR and RDW levels may be used as markers of inflammation to help clinically manage patients with TB and to determine disease severity.
Literature
2.
go back to reference Nunn, P., B. Williams, K. Floyd, C. Dye, G. Elzinga, et al. 2005. Tuberculosis control in the era of HIV. Nature Reviews Immunology 5: 819–826.PubMedCrossRef Nunn, P., B. Williams, K. Floyd, C. Dye, G. Elzinga, et al. 2005. Tuberculosis control in the era of HIV. Nature Reviews Immunology 5: 819–826.PubMedCrossRef
3.
go back to reference Tozkoparan, E., O. Deniz, E. Ucar, H. Bilgic, and K. Ekiz. 2007. Changes in platelet count and indices in pulmonary tuberculosis. Clinical Chemistry and Laboratory Medicine 45: 1009–1013.PubMedCrossRef Tozkoparan, E., O. Deniz, E. Ucar, H. Bilgic, and K. Ekiz. 2007. Changes in platelet count and indices in pulmonary tuberculosis. Clinical Chemistry and Laboratory Medicine 45: 1009–1013.PubMedCrossRef
4.
go back to reference Unsal, E., S. Aksaray, D. Köksal, and T. Sipit. 2005. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgraduate Medical Journal 81: 604–607.PubMedCentralPubMedCrossRef Unsal, E., S. Aksaray, D. Köksal, and T. Sipit. 2005. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgraduate Medical Journal 81: 604–607.PubMedCentralPubMedCrossRef
5.
go back to reference Sahin, F., E. Yazar, and P. Yildiz. 2012. Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidisciplinary Respiratory Medicine 7: 38.PubMedCentralPubMedCrossRef Sahin, F., E. Yazar, and P. Yildiz. 2012. Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidisciplinary Respiratory Medicine 7: 38.PubMedCentralPubMedCrossRef
6.
go back to reference Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138–150.PubMedCrossRef Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138–150.PubMedCrossRef
7.
go back to reference Jo, Y.H., K. Kim, J.H. Lee, et al. 2013. Red cell distribution width is a prognostic factor in severe sepsis and septic shock. American Journal of Emergency Medicine 31: 545–548.PubMedCrossRef Jo, Y.H., K. Kim, J.H. Lee, et al. 2013. Red cell distribution width is a prognostic factor in severe sepsis and septic shock. American Journal of Emergency Medicine 31: 545–548.PubMedCrossRef
8.
go back to reference Sincer, I., A. Zorlu, M.B. Yilmaz, et al. 2012. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart & Lung 41: 238–243.CrossRef Sincer, I., A. Zorlu, M.B. Yilmaz, et al. 2012. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart & Lung 41: 238–243.CrossRef
9.
go back to reference Felker, G.M., L.A. Allen, S.J. Pocock, et al. 2007. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. Journal of the American College of Cardiology 50: 40–47.PubMedCrossRef Felker, G.M., L.A. Allen, S.J. Pocock, et al. 2007. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. Journal of the American College of Cardiology 50: 40–47.PubMedCrossRef
10.
go back to reference Dabbah, S., H. Hammerman, W. Markiewicz, et al. 2010. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. American Journal of Cardiology 105: 312–317.PubMedCrossRef Dabbah, S., H. Hammerman, W. Markiewicz, et al. 2010. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. American Journal of Cardiology 105: 312–317.PubMedCrossRef
11.
go back to reference Braun, E., E. Domany, Y. Kenig, et al. 2011. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Critical Care 15: R194.PubMedCentralPubMedCrossRef Braun, E., E. Domany, Y. Kenig, et al. 2011. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Critical Care 15: R194.PubMedCentralPubMedCrossRef
12.
go back to reference Thomsen, M., T.S. Ingebrigtsen, J.L. Marott, M. Dahl, P. Lange, J. Vestbo, et al. 2013. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309: 2353–2361.PubMedCrossRef Thomsen, M., T.S. Ingebrigtsen, J.L. Marott, M. Dahl, P. Lange, J. Vestbo, et al. 2013. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309: 2353–2361.PubMedCrossRef
13.
go back to reference Goldenberg, A.S. 1996. Hematologic abnormalities and mycobacterial infection. In Tuberculosis, ed. N.R. Williams and G.M. Stuart, 645–647. Boston: Little – Brown Company. Goldenberg, A.S. 1996. Hematologic abnormalities and mycobacterial infection. In Tuberculosis, ed. N.R. Williams and G.M. Stuart, 645–647. Boston: Little – Brown Company.
14.
go back to reference Ahsen, A., M.S. Ulu, S. Yuksel, K. Demir, M. Uysal, M. Erdogan, et al. 2013. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36: 1357–1362.PubMedCrossRef Ahsen, A., M.S. Ulu, S. Yuksel, K. Demir, M. Uysal, M. Erdogan, et al. 2013. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36: 1357–1362.PubMedCrossRef
15.
go back to reference Ertaş, G., O. Sönmez, M. Turfan, S. Kul, E. Erdoğan, A. Tasal, et al. 2013. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. Journal of the Neurological Sciences 324: 49–52.PubMedCrossRef Ertaş, G., O. Sönmez, M. Turfan, S. Kul, E. Erdoğan, A. Tasal, et al. 2013. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. Journal of the Neurological Sciences 324: 49–52.PubMedCrossRef
16.
go back to reference 1961. National Tuberculosis Association of the USA: Diagnostic standards and classification of tuberculosis. New York: National Tuberculosis Association. 1961. National Tuberculosis Association of the USA: Diagnostic standards and classification of tuberculosis. New York: National Tuberculosis Association.
17.
go back to reference Seaton, A., D. Seaton, and A.G. Leitch. 1989. Crofton and Douglas’s respiratory diseases, 4th ed, 409–410. Oxford: Blackwell. Seaton, A., D. Seaton, and A.G. Leitch. 1989. Crofton and Douglas’s respiratory diseases, 4th ed, 409–410. Oxford: Blackwell.
18.
go back to reference Yaranal, P.J., T. Umashankar, and S.G. Harish. 2013. Hematological profile in pulmonary tuberculosis. International Journal of Health and Rehabilation Sciences 2: 50–55. Yaranal, P.J., T. Umashankar, and S.G. Harish. 2013. Hematological profile in pulmonary tuberculosis. International Journal of Health and Rehabilation Sciences 2: 50–55.
19.
go back to reference Bazick, H.S., D. Chang, K. Mahadevappa, et al. 2011. Red cell distribution width and all-cause mortality in critically ill patients. Critical Care Medicine 39: 1913–1921.PubMedCentralPubMedCrossRef Bazick, H.S., D. Chang, K. Mahadevappa, et al. 2011. Red cell distribution width and all-cause mortality in critically ill patients. Critical Care Medicine 39: 1913–1921.PubMedCentralPubMedCrossRef
20.
go back to reference Baynes, R.D., H. Flax, T.H. Bothwell, W.R. Bezwoda, A.P. MacPhail, P. Atkinson, et al. 1986. Haematological and iron-related measurements in active pulmonary tuberculosis. Scandinavian Journal of Haematology 36: 280–287.PubMedCrossRef Baynes, R.D., H. Flax, T.H. Bothwell, W.R. Bezwoda, A.P. MacPhail, P. Atkinson, et al. 1986. Haematological and iron-related measurements in active pulmonary tuberculosis. Scandinavian Journal of Haematology 36: 280–287.PubMedCrossRef
21.
go back to reference Olaniyi, J.A., and Y.A. Aken’Ova. 2003. Haematological profile of patients with pulmonary tuberculosis in Ibadan, Nigeria. African Journal of Medicine and Medical Sciences 32: 239–242.PubMed Olaniyi, J.A., and Y.A. Aken’Ova. 2003. Haematological profile of patients with pulmonary tuberculosis in Ibadan, Nigeria. African Journal of Medicine and Medical Sciences 32: 239–242.PubMed
22.
go back to reference Das, B.S., U. Devi, C. Mohan Rao, V.K. Srivastava, P.K. Rath, and B.S. Das. 2003. Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis. British Journal of Nutrition 90: 541–550.PubMedCrossRef Das, B.S., U. Devi, C. Mohan Rao, V.K. Srivastava, P.K. Rath, and B.S. Das. 2003. Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis. British Journal of Nutrition 90: 541–550.PubMedCrossRef
23.
go back to reference Akintunde, E.O., W.A. Shokunbi, and C.O. Adekunle. 1995. Leucocyte count, platelet count and erythrocyte sedimentation rate in pulmonary tuberculosis. African Journal of Medicine and Medical Sciences 24: 131–134.PubMed Akintunde, E.O., W.A. Shokunbi, and C.O. Adekunle. 1995. Leucocyte count, platelet count and erythrocyte sedimentation rate in pulmonary tuberculosis. African Journal of Medicine and Medical Sciences 24: 131–134.PubMed
24.
go back to reference Kang, Y.A., S.Y. Kwon, H.I. Yoon, J.H. Lee, and C.T. Lee. 2009. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean Journal of Internal Medicine 24: 337–342.PubMedCentralPubMedCrossRef Kang, Y.A., S.Y. Kwon, H.I. Yoon, J.H. Lee, and C.T. Lee. 2009. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean Journal of Internal Medicine 24: 337–342.PubMedCentralPubMedCrossRef
25.
go back to reference Celikbilek, M., S. Dogan, O. Ozbakır, G. Zararsız, H. Kücük, S. Gürsoy, A. Yurci, K. Güven, and M. Yücesoy. 2013. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of Clinical Laboratory Analysis 27: 72–76.PubMedCrossRef Celikbilek, M., S. Dogan, O. Ozbakır, G. Zararsız, H. Kücük, S. Gürsoy, A. Yurci, K. Güven, and M. Yücesoy. 2013. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of Clinical Laboratory Analysis 27: 72–76.PubMedCrossRef
26.
go back to reference Okyay, G.U., S. Inal, K. Oneç, R.E. Er, O. Paşaoğlu, H. Paşaoğlu, U. Derici, and Y. Erten. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Renal Failure 35: 29–36.PubMedCrossRef Okyay, G.U., S. Inal, K. Oneç, R.E. Er, O. Paşaoğlu, H. Paşaoğlu, U. Derici, and Y. Erten. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Renal Failure 35: 29–36.PubMedCrossRef
27.
go back to reference Güngör B, Ozcan KS, Erdinler I, Ekmekçi A, Alper AT, Osmonov D, Calık N, Akyuz S, Toprak E, Yılmaz H, Yıldırım A, Bolca O. Elevated levels of RDW is associated with non-valvular atrial fibrillation. J Thromb Thrombolysis 2013. Güngör B, Ozcan KS, Erdinler I, Ekmekçi A, Alper AT, Osmonov D, Calık N, Akyuz S, Toprak E, Yılmaz H, Yıldırım A, Bolca O. Elevated levels of RDW is associated with non-valvular atrial fibrillation. J Thromb Thrombolysis 2013.
28.
go back to reference Gary, T., M. Pichler, K. Belaj, F. Hafner, A. Gerger, H. Froehlich, P. Eller, E. Pilger, and M. Brodmann. 2013. Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One 8: e56745.PubMedCentralPubMedCrossRef Gary, T., M. Pichler, K. Belaj, F. Hafner, A. Gerger, H. Froehlich, P. Eller, E. Pilger, and M. Brodmann. 2013. Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One 8: e56745.PubMedCentralPubMedCrossRef
29.
go back to reference Holub, M., O. Beran, N. Kaspříková, and P. Chalupa. 2012. Neutrophil to lymphocyte count ratio as a biomarker of bacterial infections. Central European Journal of Medicine 7: 258–261. Holub, M., O. Beran, N. Kaspříková, and P. Chalupa. 2012. Neutrophil to lymphocyte count ratio as a biomarker of bacterial infections. Central European Journal of Medicine 7: 258–261.
30.
go back to reference Yoon, N.B., C. Son, and S.J. Um. 2013. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Annals of Laboratory Medicine 33: 105–110.PubMedCentralPubMedCrossRef Yoon, N.B., C. Son, and S.J. Um. 2013. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Annals of Laboratory Medicine 33: 105–110.PubMedCentralPubMedCrossRef
31.
go back to reference Ozsu, S., Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2014. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis 20: 365–370.PubMedCrossRef Ozsu, S., Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2014. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis 20: 365–370.PubMedCrossRef
32.
go back to reference Ozsu, S., Y. Abul, A. Gulsoy, Y. Bulbul, S. Yaman, and T. Ozlu. 2012. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung 190: 319–326.PubMedCrossRef Ozsu, S., Y. Abul, A. Gulsoy, Y. Bulbul, S. Yaman, and T. Ozlu. 2012. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung 190: 319–326.PubMedCrossRef
33.
go back to reference Kurt, O.K., and N. Yildiz. 2013. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome. Blood Coagulation and Fibrinolysis 24: 371–374.PubMedCrossRef Kurt, O.K., and N. Yildiz. 2013. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome. Blood Coagulation and Fibrinolysis 24: 371–374.PubMedCrossRef
34.
go back to reference Mirsaeidi, M., P. Peyrani, S. Aliberti, G. Filardo, J. Bordon, F. Blasi, et al. 2010. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 137: 416–420.PubMedCrossRef Mirsaeidi, M., P. Peyrani, S. Aliberti, G. Filardo, J. Bordon, F. Blasi, et al. 2010. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 137: 416–420.PubMedCrossRef
35.
go back to reference Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, Cincin A. 2013. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens. Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, Cincin A. 2013. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens.
36.
go back to reference Yavuzcan, A., M. Caglar, Y. Ustun, S. Dilbaz, I. Ozdemir, E. Yildiz, A. Ozkara, and S. Kumru. 2013. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. Journal of the Turkish German Gynecological Association 14: 210–215.PubMedCentralPubMedCrossRef Yavuzcan, A., M. Caglar, Y. Ustun, S. Dilbaz, I. Ozdemir, E. Yildiz, A. Ozkara, and S. Kumru. 2013. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. Journal of the Turkish German Gynecological Association 14: 210–215.PubMedCentralPubMedCrossRef
37.
go back to reference Feng, J.F., Y. Huang, Q. Zhao, and Q.X. Chen. 2013. Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. ScientificWorldJournal 2013: 504365.PubMedCentralPubMed Feng, J.F., Y. Huang, Q. Zhao, and Q.X. Chen. 2013. Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. ScientificWorldJournal 2013: 504365.PubMedCentralPubMed
Metadata
Title
The Relationship Between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity
Authors
Ozlem Abakay
Abdurrahman Abakay
Hadice Selimoglu Sen
Abdullah C. Tanrikulu
Publication date
01-04-2015
Publisher
Springer US
Published in
Inflammation / Issue 2/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9978-y

Other articles of this Issue 2/2015

Inflammation 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.